Background There were few reports of hepatitis C virus (HCV) treatment results with interferon-based regimens in indigenous populations. a higher discontinuation rate because of unwanted effects in those treated with pegylated interferon and ribavirin for genotype 1 (52.2%). Seven of 15 genotype 1 individuals treated with pegylated interferon, ribavirin and telaprevir or boceprevir accomplished SVR… Continue reading Background There were few reports of hepatitis C virus (HCV) treatment